Skip to content
Rounds
0:00 / 0:00

Covid-19: Researcher blows the whistle on data integrity issues in Pfizer’s vaccine trial

The BMJ

45K subscribers • 26 videos on Rounds • Health institution

YouTube
  • Published by The BMJ, one of the health institutions Rounds lists. Nobody has recommended it in the communities yet, so it ranks below community picks.
  • The description links 1 paper.
  • May be out of date. Findings or guidance it presents have likely moved on.
  • Debated among experts. Its central claim is contested, so look for the other side.

Assumes interest and some biology. Education, not medical advice.

3.9M views4 years ago

Immunity and infectionEvidence and public healthVaccinesInfectious diseaseReading studies

An investigation explores allegations of data falsification and patient safety issues at a Pfizer Covid-19 vaccine trial site in Texas.

For researchers who were testing Pfizer’s vaccine at several sites in Texas during that autumn, speed may have come at the cost of data integrity and patient safety. A regional director who was employed at the research organisation Ventavia Research Group has told The BMJ that the company falsified data, unblinded patients, employed inadequately trained vaccinators, and was slow to follow up on adverse events reported in Pfizer’s pivotal phase III trial. Staff who conducted quality control checks were overwhelmed by the volume of problems they were finding. After repeatedly notifying Ventavia of these problems, the regional director, Brook Jackson , emailed a complaint to the US Food and Drug Administration (FDA). Jackson has provided The BMJ with dozens of internal company documents, photos, audio recordings, and emails. Read the full investigation: Covid-19: Researcher blows the whistle on data integrity issues in Pfizer’s vaccine trial bmj.com/content/375/bmj.n2635

Why it's here

From a health institution

The BMJ is on Rounds' list of health institutions, and this upload is one of its most-watched lectures or explainers. Nobody has recommended it in the communities yet, so it ranks below community picks.